Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01192126 · ClinicalTrials.gov registry record · NA

A Study to Evaluate the Product Performance of a Daily Disposable Contact Lens

A NA study, sponsored by Bausch & Lomb Incorporated.

Completed
Registry status
NA
Development phase
102
Enrollment target

NCT01192126: Completed NA study, sponsored by Bausch & Lomb Incorporated.

NCT01192126 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 102 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01192126, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.

COMPLETED
Registry status
NA
Development phase
102 participants
Enrollment target

Study Summary

The objective of the study is to evaluate the product performance of visual acuity of the Bausch + Lomb investigational daily disposable contact lenses compared to the currently marketed Johnson \& Johnson Acuvue Moist contact lenses.

Primary Outcome

Distance High contrast logMAR visual acuity (VA), difference between the test and control lens at dispensing visit and 1 week follow-up, crossover visit and 1 week follow-up.

Interventions

  • DEVICE Bausch & Lomb new daily disposable
  • DEVICE Johnson & Johnson Acuvue Moist

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2010-08
Est. Completion 2010-10
Phase NA
Bausch & Lomb Incorporated

174 total trials

What the finished NCT01192126 record still lists

NCT01192126 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Bausch & Lomb new daily disposable is the first listed.

NCT01192126 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01192126 about?

NCT01192126 is a clinical study titled "A Study to Evaluate the Product Performance of a Daily Disposable Contact Lens". The objective of the study is to evaluate the product performance of visual acuity of the Bausch + Lomb investigational daily disposable contact lenses compared to the currently marketed Johnson \& Johnson Acuvue Moist contact lenses.

What is the current status of trial NCT01192126?

This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2010-08. Estimated completion is 2010-10.

What interventions are being tested in trial NCT01192126?

The interventions under investigation include: Bausch & Lomb new daily disposable (DEVICE), Johnson & Johnson Acuvue Moist (DEVICE).

Who is sponsoring clinical trial NCT01192126?

This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01192126's enrollment target sits among peer trials

102 837th of 2000 higher than 1,161 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03704662 · 102 participants · NA

    Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

  • NCT04174742 · 102 participants

    Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

  • NCT04275362 · 102 participants

    Gait Analysis of a Lateral-Pivot Design Total Knee Replacement

  • NCT04541082 · 102 participants · Phase 1

    Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01192126, the US trial registry maintained by the National Library of Medicine. NCT01192126 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.